-
Are Health Care Professionals’ Implicit and Explicit Attitudes Toward Conventional Disease-Modifying Antirheumatic Drugs Associated With Those of Their Patients?
van Heuckelum, M., Hebing, R. C. F., Vandeberg, L., Linn, A. J., Flendrie, M., Nurmohamed, M., van Dulmen, S., van den Ende, C. H. M. & van den Bemt, B. J. F., 1 Mar 2021, In: Arthritis care and research. 73, 3, p. 364-373 10 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory Diseases
van Lint, J. A., Jessurun, N. T., Hebing, R. C. F., Hoentjen, F., Tas, S. W., Vonkeman, H. E., van Doorn, M. B. A., Sobels, A., Spuls, P. I., van Puijenbroek, E. P., Nurmohamed, M. T. & van den Bemt, B. J. F., 1 Sept 2020, In: Drug safety. 43, 9, p. 917-925 9 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up
Vogelzang, E. H., Hebing, R. C. F., Nurmohamed, M. T., van Kuijk, A. W. R., Kruijff, J. W. F., l'Ami, M. J., Krieckaert, C. L. M. & Wolbink, G., 2018, In: PLoS ONE. 13, 10, p. e0205125 e0205125.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
